<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0207554.ref274">
 <label>274</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Edelman</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Tacket</surname>
   <given-names>CO</given-names>
  </name>, 
  <name>
   <surname>Wasserman</surname>
   <given-names>SS</given-names>
  </name>, 
  <name>
   <surname>Bodison</surname>
   <given-names>SA</given-names>
  </name>, 
  <name>
   <surname>Perry</surname>
   <given-names>JG</given-names>
  </name>, 
  <name>
   <surname>Mangiafico</surname>
   <given-names>JA</given-names>
  </name>. 
  <article-title>Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218</article-title>. 
  <source>Am J Trop Med Hyg</source>
  <year>2000</year>;
  <volume>62</volume>(
  <issue>6</issue>):
  <fpage>681</fpage>â€“
  <lpage>685</lpage>. 30 ref. 
  <?supplied-pmid 11304054?>
  <pub-id pub-id-type="pmid">11304054</pub-id>
 </mixed-citation>
</ref>
